Naijin Xu
- Topics
- Bladder and Urothelial Cancer Treatments (3 papers)Extracellular vesicles in disease (2 papers)Renal cell carcinoma treatment (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Naijin Xu
20 papers receiving 504 citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 253
- Oncology 72
- Organic Chemistry 68
- Cancer Research 61
- Pharmacology 54
Countries citing papers authored by Naijin Xu
This map shows the geographic impact of Naijin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naijin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naijin Xu more than expected).
Fields of papers citing papers by Naijin Xu
This network shows the impact of papers produced by Naijin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naijin Xu. The network helps show where Naijin Xu may publish in the future.
Co-authorship network of co-authors of Naijin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Naijin Xu. A scholar is included among the top collaborators of Naijin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naijin Xu. Naijin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 20 | |
| 3 | 37 | |
| 4 | 17 | |
| 5 | 11 | |
| 6 | 20 | |
| 7 | Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium. | 11 |
| 8 | 1 | |
| 9 | 64 | |
| 10 | 28 | |
| 11 | 20 | |
| 12 | 152 | |
| 13 | 29 | |
| 14 | 2 | |
| 15 | 42 | |
| 16 | 5 | |
| 17 | 10 | |
| 18 | Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. | 4 |
| 19 | 4 | |
| 20 | 16 |
About Naijin Xu
Naijin Xu is a scholar working on Pharmacology, Cancer Research and Immunology, having authored 20 papers that have together received 513 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Extracellular vesicles in disease (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Pharmacology (54 citations), Cancer Research (61 citations) and Molecular Biology (253 citations). Naijin Xu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Hui Liu, Guanqun Chen, Peng Huang, Xun Xu, Wenfeng Lin, Chunxiao Liu, Masami Watanabe, Chaoming Li, Yasutomo Nasu and Motoo Araki. Their work appears in journals such as Biochemical and Biophysical Research Communications, Molecules and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.